Earningsreport

Q2/2022 3/31/2022 EPS -0.140 ZacksConsensus -0.160 ActVsEst 0.020 - Beat

Anavex Life Sciences Corp.  (AVXL) 
NASDAQ:AMEX Investor Relations: anavex.com/share-data